A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
Clinical trial NCT05548543 · COMPLETED
Trial details
- NCT number
- NCT05548543
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-17
- Primary completion
- 2022-12-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.